Post-contrast Susceptibility Weighted Imaging in Multiple Sclerosis MRI Improves the Detection of Enhancing Lesions

Pablo Naval-Baudin1,2,3,4, Karen Pérez-Alfonso5, Albert Castillo-Pinar5

  • 1Radiology Department, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Carrer de Feixa Llarga SN, 08907, Barcelona, Spain. pablo.naval.idi@gencat.cat.

PubMed
Abstract

Insights

Adding post-contrast susceptibility-weighted imaging (SWI+C) to standard contrast-enhanced T1-weighted imaging (T1WI+C) improves the detection of active inflammatory lesions in multiple sclerosis (MS) patients. This enhanced MRI approach also increases agreement between observers for MS lesion identification.

Area of Science:

  • Neuroimaging
  • Radiology
  • Neurology

Background:

  • Magnetic Resonance Imaging (MRI) is crucial for monitoring multiple sclerosis (MS).
  • Contrast-enhanced T1-weighted imaging (T1WI+C) identifies active inflammatory lesions by visualizing blood-brain barrier breakdown.
  • Susceptibility-weighted imaging (SWI) can detect MS-specific features, and post-contrast SWI (SWI+C) may reveal contrast-enhancing lesions due to a "T1 shine-through effect".

Purpose of the Study:

  • To evaluate if SWI+C, in addition to T1WI+C, improves the detection of enhancing lesions in MS patients.
  • To assess the impact of combined SWI+C and T1WI+C on lesion detection and interobserver agreement.

Main Methods:

  • Retrospective review of MRI scans from 310 MS patients acquired with a 3T scanner.
  • Standardized MRI protocol included both T1WI+C and SWI+C.
  • Independent image evaluation by a neuroradiologist and a radiology resident comparing T1WI+C alone versus T1WI+C plus SWI+C.

Main Results:

  • The neuroradiologist detected 117 lesions on T1WI+C and 123 lesions with the addition of SWI+C.
  • The resident detected 108 lesions on T1WI+C and 121 lesions with the addition of SWI+C.
  • Interobserver agreement improved from 0.981 to 1.00 with the combined imaging approach.

Conclusions:

  • SWI+C consistently enhances the detection of active inflammatory MS lesions compared to T1WI+C alone.
  • The addition of SWI+C improves interobserver agreement in lesion detection.
  • Standardized combined T1WI+C and SWI+C may enable earlier detection of MS disease activity and improve monitoring, potentially optimizing treatment decisions.